It is likely that MASLD in these contexts arises from a complex and multifactorial interplay between insulin resistance and hormonal imbalances involving pathways such as RAAS signaling and activation of the mineralocorticoid receptor (MR) [10,11,12,13,14]. Here, NR3C2 is linked to Insulin resistance.